OptimizeRx (OPRX) Revenue & Revenue Breakdown
OptimizeRx Revenue Highlights
Latest Revenue (Y)
$71.52M
Latest Revenue (Q)
$21.31M
OptimizeRx Revenue by Period
OptimizeRx Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $71.52M | 14.53% |
| 2022-12-31 | $62.45M | 1.89% |
| 2021-12-31 | $61.29M | 41.51% |
| 2020-12-31 | $43.31M | 76.08% |
| 2019-12-31 | $24.60M | 15.99% |
| 2018-12-31 | $21.21M | 74.86% |
| 2017-12-31 | $12.13M | 56.45% |
| 2016-12-31 | $7.75M | 7.35% |
| 2015-12-31 | $7.22M | 11.04% |
| 2014-12-31 | $6.50M | 31.19% |
| 2013-12-31 | $4.96M | 141.96% |
| 2012-12-31 | $2.05M | 84.32% |
| 2011-12-31 | $1.11M | 1464.09% |
| 2010-12-31 | $71.06K | 165.93% |
| 2009-12-31 | $26.72K | -68.07% |
| 2008-12-31 | $83.69K | -16.58% |
| 2007-12-31 | $100.32K | - |
OptimizeRx generated $71.52M in revenue during NA 2023, up 14.53% compared to the previous quarter, and up 337.26% compared to the same period a year ago.
OptimizeRx Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $21.31M | 13.27% |
| 2024-06-30 | $18.81M | -4.46% |
| 2024-03-31 | $19.69M | -30.59% |
| 2023-12-31 | $28.37M | 73.71% |
| 2023-09-30 | $16.33M | 18.19% |
| 2023-06-30 | $13.82M | 6.27% |
| 2023-03-31 | $13.00M | -33.84% |
| 2022-12-31 | $19.65M | 30.29% |
| 2022-09-30 | $15.09M | 7.92% |
| 2022-06-30 | $13.98M | 1.80% |
| 2022-03-31 | $13.73M | -32.40% |
| 2021-12-31 | $20.31M | 25.97% |
| 2021-09-30 | $16.12M | 18.34% |
| 2021-06-30 | $13.63M | 21.34% |
| 2021-03-31 | $11.23M | -31.64% |
| 2020-12-31 | $16.43M | 56.16% |
| 2020-09-30 | $10.52M | 19.76% |
| 2020-06-30 | $8.78M | 15.80% |
| 2020-03-31 | $7.58M | 2.78% |
| 2019-12-31 | $7.38M | 47.51% |
| 2019-09-30 | $5.00M | -28.60% |
| 2019-06-30 | $7.01M | 34.49% |
| 2019-03-31 | $5.21M | -20.82% |
| 2018-12-31 | $6.58M | 21.49% |
| 2018-09-30 | $5.42M | 6.19% |
| 2018-06-30 | $5.10M | 24.01% |
| 2018-03-31 | $4.11M | 2.63% |
| 2017-12-31 | $4.01M | 29.15% |
| 2017-09-30 | $3.10M | 8.26% |
| 2017-06-30 | $2.87M | 33.17% |
| 2017-03-31 | $2.15M | -6.13% |
| 2016-12-31 | $2.29M | 28.35% |
| 2016-09-30 | $1.79M | -6.65% |
| 2016-06-30 | $1.91M | 8.74% |
| 2016-03-31 | $1.76M | -12.91% |
| 2015-12-31 | $2.02M | 0.64% |
| 2015-09-30 | $2.01M | 17.71% |
| 2015-06-30 | $1.71M | 14.65% |
| 2015-03-31 | $1.49M | -29.54% |
| 2014-12-31 | $2.11M | 30.30% |
| 2014-09-30 | $1.62M | 11.42% |
| 2014-06-30 | $1.45M | 10.39% |
| 2014-03-31 | $1.32M | -27.24% |
| 2013-12-31 | $1.81M | 31.87% |
| 2013-09-30 | $1.37M | 24.36% |
| 2013-06-30 | $1.10M | 64.96% |
| 2013-03-31 | $669.29K | -10.85% |
| 2012-12-31 | $750.72K | 65.67% |
| 2012-09-30 | $453.15K | -12.08% |
| 2012-06-30 | $515.42K | 56.47% |
| 2012-03-31 | $329.40K | 1.07% |
| 2011-12-31 | $325.91K | 70.11% |
| 2011-09-30 | $191.59K | -4.29% |
| 2011-06-30 | $200.17K | -49.17% |
| 2011-03-31 | $393.84K | 3079.74% |
| 2010-12-31 | $12.39K | -69.55% |
| 2010-09-30 | $40.68K | 143.28% |
| 2010-06-30 | $16.72K | 1203.20% |
| 2010-03-31 | $1.28K | -91.50% |
| 2009-12-31 | $15.10K | 118.51% |
| 2009-09-30 | $6.91K | 100.29% |
| 2009-06-30 | $3.45K | 171.36% |
| 2009-03-31 | $1.27K | -91.73% |
| 2008-12-31 | $15.37K | 1283.35% |
| 2008-09-30 | $1.11K | -93.34% |
| 2008-06-30 | $16.68K | -66.99% |
| 2008-03-31 | $50.53K | - |
OptimizeRx generated $21.31M in revenue during Q3 2024, up 13.27% compared to the previous quarter, and up 154.21% compared to the same period a year ago.
OptimizeRx Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PRVA | Privia Health Group | $1.66B | $422.33M |
| HQY | HealthEquity | $999.59M | $300.43M |
| DOCS | Doximity | $475.42M | $136.83M |
| ACCD | Accolade | $414.29M | $106.36M |
| CERT | Certara | $354.34M | $94.82M |
| HSTM | HealthStream | $279.06M | $73.09M |
| DH | Definitive Healthcare | $251.41M | $62.70M |
| NRC | National Research | $148.58M | $35.82M |
| OPRX | OptimizeRx | $71.52M | $21.31M |
| STRM | Streamline Health Solutions | $22.60M | $4.48B |
| FORA | Forian | $20.48M | $4.78M |
| ACON | Aclarion | $75.40K | $10.97K |